Flagship explainer
What drives HERON THERAPEUTICS, INC. /DE/’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$20.2M | FY2025 |
| |
| Income before tax | −$20.2M | FY2025 |
|
| Operating income | −$2.5M | FY2025 |
|
| $155M | FY2025 |
| |
| Ending assets | $256M | FY2025 |
|
| Beginning assets | $233M | FY2024 |
|
| $14.3M | FY2025 |
| |
| −$33.7M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-073515